HHS study shows Medicare pays 80 percent more than other countries for certain prescription drugs
FRIDAY, Oct. 26, 2018 (HealthDay News) — In an effort to cut high drug costs, the prices paid by Medicare for certain prescription drugs would be based on those in other advanced industrial nations, according to a proposal announced Oct. 25 by the Trump administration.
The move would cut costs for Medicare and save beneficiaries millions of dollars, according to an article in The New York Times.
Under a demonstration project in half the country, Medicare would create and use an “international pricing index” to decide how much to pay for drugs covered by Part B of Medicare.
A recently released study by the U.S. Department of Health and Human Services revealed that Medicare paid 80 percent more than other advanced industrial countries for some of the most expensive prescription medicines, The Times reported.
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
Age-, Joint-Specific Ultrasound Reference Values Set for Healthy Joints 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
